Skip to main content
Tata Chemicals Ltd logo

Tata Chemicals Ltd — Investor Relations & Filings

Ticker · TATACHEM ISIN · INE092A01019 LEI · 335800H6MURUA6FBOW17 BSE.NS Manufacturing
Filings indexed 2,743 across all filing types
Latest filing 2025-04-04 Regulatory Filings
Country IN India
Listing BSE.NS TATACHEM

About Tata Chemicals Ltd

https://www.tatachemicals.com/

Tata Chemicals Ltd provides chemistry-led solutions through its Basic Chemistry and Specialty Products segments. It is a leading global producer of soda ash and sodium bicarbonate, serving sectors such as glass, detergents, pharmaceuticals, and food processing. The specialty portfolio includes agro sciences, nutritional sciences, and material sciences, with a focus on prebiotics, highly dispersible silica, and crop protection through its subsidiary, Rallis India. The company operates manufacturing facilities across four continents and invests in energy sciences, specifically lithium-ion battery materials. Its operations are characterized by innovation-driven R&D and sustainable manufacturing practices. By integrating science with sustainability, the company delivers essential ingredients and specialized solutions to a global customer base across industrial and agricultural markets.

Recent filings

Filing Released Lang Actions
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, certifying details of securities dematerialised/rematerialised for the quarter ended March 31, 2025. It is addressed to depository services and stock exchanges and is a compliance certification rather than a financial report or announcement of financial results. The document length is short (1214 characters) and it serves as a regulatory compliance filing. It does not contain financial statements, management discussion, or report data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and regulatory announcements that do not fit other categories.
2025-04-04 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, certifying details of securities dematerialised/rematerialised for the quarter ended March 31, 2025. It is addressed to depository services and stock exchanges and signed by the company secretary. The document is short (1214 characters) and serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which covers officer certifications and compliance documents that do not fit other categories.
2025-04-04 English
Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015
Board/Management Information Classification · 100% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) regarding changes in the roles and designations of senior management personnel effective April 1, 2025. It references Regulation 30 of the SEBI Listing Regulations, which pertains to disclosure of material events including management changes. The content includes detailed profiles and reasons for the changes in senior management roles. There is no financial data, earnings information, or report publication mentioned. The document is clearly about management changes and not about financial results or other report types. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 4135 characters, which is consistent with a detailed announcement rather than a brief notice or report publication announcement.
2025-04-01 English
Change in Management
Board/Management Information Classification · 100% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) regarding changes in the roles and designations of senior management personnel effective April 1, 2025. It references Regulation 30 of the SEBI Listing Regulations, which pertains to disclosure of material events including management changes. The content includes detailed profiles and new roles of two senior management individuals. There is no financial data, earnings information, or report publication mentioned. The document is clearly about management changes and not an earnings release, annual report, or other financial filing. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 4135 characters, which is consistent with a detailed management change announcement rather than a brief notice or report publication announcement.
2025-04-01 English
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them of a scheduled meeting with an analyst/institutional investor. It references SEBI Listing Obligations and Disclosure Requirements Regulation 30(6), which pertains to disclosure of events or information. The content is an intimation of an upcoming investor meeting, explicitly stating no unpublished price sensitive information will be shared. The document length is short (1534 characters) and does not contain any financial data, report, or detailed presentation. It is an announcement related to investor relations but not a full investor presentation or financial report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2025-03-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of an analyst/institutional investor meeting. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of events or information. The content is about informing the exchanges of an upcoming investor meeting, with no financial data, report, or detailed presentation included. The document is short (1539 characters) and serves as an announcement or intimation rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2025-03-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.